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WHAT IS EVIDENCE-BASED DERMATOLOGY?
 Although the term ‘evidence - based’ has been 
recently introduced, the evidence based idea 
is very old indeed; in ancient world, Aristoteles 
placed a rule for all investigators of the time that 
they should support each of their statements with 
all available evidence.
 In 1991, Sackett defined the term evidence 
based medicine (EBM) as a conscientious, explicit 
and judicious use of current best evidence in mak-
ing decisions about the care of individual patients. 
Some other authors define EBM as the best way 
of linking and integrating clinical research with 
clinical practice. 
 Until now, our decisions on reaching the diag-
nosis and especially on the choice of therapy for 
our patients have been based on data acquired 
through our experience, from  the experience of 
our colleagues, and from the routine at the particu-
lar medical institution. The best therapy for each 
individual patient is chosen according to these 
data. However, the problem is that this practice 
may be obsolete and too infrequently submitted 
to critical review. In the literature, this model of 
performance is called ‘eminence based medicine’. 
The result of this approach is that patients are be-
ing differently treated at different hospitals, which 
means that not all patients have due access to the 
same conditions of medical treatment.
 EBM relies on the importance and value of re-
search evidence, however, just the evidence is 
not enough to make a definitive decision, as it de-
pends on the benefit to risk ratio, cost, physician’s 
experience, and patient’s preference.
 The most important evidence derives from re-
views of controlled randomized trials conducted 
by different institutions. The most reliable sources 
of evidence are Cochrane Library (which also in-
cludes results of Cochrane Skin Group), Medline, 
Embase, secondary publications, primary publica-
tions, and national guidelines that should not be 
mistaken for EBM.
 As dermatologists, we are interested in evi-
dence based dermatology in particular, which is 
defined as the use of EBM for people with skin 
problems. What is specific about the skin?
 Skin is a large and visible organ, however, 
it is not just an organ covering the body but a 
sensitive dynamic barrier between the outer world 
and internal organs. It is also a very important or-
gan of social and sexual contact. All these facts 
probably are the reason why, unlike other organs 
where up to some 100 different diseases are usu-
ally described, dermatology textbooks list about 
2000 different skin conditions. 
 Skin manifestations can be caused by primary 
skin disease or some systemic diseases can have 
cutaneous manifestations. According to literature 
data, skin disorders affect about 20% of the gen-
eral population at any time. As skin manifestations 
are readily visible, they can cause greater distress 
than other more serious but ‘invisible’ problems.
As in other disciplines, the past few decades have 
seen an impressive increase in clinical research 
in dermatology. Yet, the problem is that the quality 
of randomized controlled trials in dermatology has 
not followed the progress in research. What could 
be the reasons for that?
 Here are some possible answers: there are 
not enough quality randomized controlled trials; 
in dermatology there are about 1000 very rare 
diseases with high mortality that could only be 
reviewed through international cooperation; skin 
changes are visible, giving patients an opportunity 
for self-monitoring and therapy modification; there 
are quite a number of studies reported in popu-
lar literature and providing wrong data and wrong 
picture; and a number of randomized studies are 
conducted by pharmaceutical industry, thus raising 
doubt about the realiability of data thus obtained.
 How could we make our contribution to solving 
these problems?
 The best way is to publisih results of our stud-
ies as well as interesting case reports substanti-
ated by controlled data. Only the results published 
in publications with international relevance have a 
real value.
 And the last but not the least, we are proud to 
have a journal indexed in two relevant databases 
(Excerpta Medica/Embase and Excerpta Medica/
Medline), which offers us an opportunity to inform 
the international scientific community on our re-
searches as well as on diagnostic and therapeutic 
doubts and achievements.
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